The Ophthalmologist / Issues / 2026 / April / Hydrus®: The Long-Term Evidence
Research & Innovations Cataract Glaucoma Sponsored

Hydrus®: The Long-Term Evidence

Professor Gus Gazzard* outlines the five-year results of the HORIZON study, evaluating the safety and efficacy of the Hydrus® Microstent

Sponsored By Alcon 4/24/2026 6 min read

Share

We're sorry, but this content isn't available in your region.

Related Content

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: